Evaluation of prevalent and incident ovarian cancer co-morbidity

BACKGROUND: The peak in incidence of ovarian cancer occurs around 65 years and concurrent increasing risk by age for a number of diseases strongly influence treatment and prognosis. The aim was to explore prevalence and incidence of co-morbidity in ovarian cancer patients compared with the general p...

Descripción completa

Detalles Bibliográficos
Autores principales: Stålberg, K, Svensson, T, Granath, F, Kieler, H, Tholander, B, Lönn, S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2012
Materias:
Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3364567/
https://www.ncbi.nlm.nih.gov/pubmed/22549177
http://dx.doi.org/10.1038/bjc.2012.164

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3364567/
https://www.ncbi.nlm.nih.gov/pubmed/22549177
http://dx.doi.org/10.1038/bjc.2012.164

Ejemplares similares